The European Commission (EC) has approved Bio-Thera Solutions Inc.’s BAT2206 (ustekinumab), a biosimilar referencing Stelara.

Ken McFarlane of CluePoints shares insight on better, smarter ways to detect risk, streamline data review, and automate ...

Bio-Rad Laboratories has introduced a new range of StarBright Dyes, providing greater choice and flexibility for spectral ...

With over two decades of experience, Katcheves previously served at Teva, Bristol Myers Squibb, and Lonza Group.

The European Commission has granted marketing authorization for Yeytuo (lenacapavir)—Gilead Sciences Inc.’s twice-yearly ...

AbbVie has agreed to acquire Gilgamesh Pharmaceuticals Inc.’s lead investigational candidate, currently in clinical ...

Genentech, a member of the Roche Group, has broken ground on its newest U.S. manufacturing site in Holly Springs, North ...

Gary Ellsworth, Head of North America Alliance Management, IQVIA shares insight on key trends driving outsourcing in today’s ...

The United States Food and Drug Administration (FDA) has suspended Valneva SE’s license for IXCHIQ, citing four new reports ...

The company expands its API facility in Waltham, MA, to support the development and manufacturing of peptide therapies.

Adva Biotechnology Ltd. and Autolomous Ltd. have joined forces to co-lead an early adopter initiative focused on digitizing, ...

Incyte has appointed Soni Basi as Executive Vice President and Chief Human Resources Officer (CHRO) effective August 25, 2025 ...